Thromboembolic and bleeding risk stratification according to the EHRA valvular heart disease classification in patients with atrial fibrillation

ConclusionThis systematic analysis in real life conditions shows that distinguishing AF patients according to the new EHRA valve classification could be relevant for creating more homogenous groups of patients in terms of TE and bleeding risk. This clearer classification than the previous one should be useful as in clinical research for harmonization of studies, as well as in clinical practice for targeted choices of OAC therapy.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research